unable to make it to the door; Couldn't open eyes most of time by then too weak,weak,; must have been dehydrated; feeling generally unwell, felt sicker than the flu,; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (feeling generally unwell, felt sicker than the flu,), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to make it to the door), ASTHENIA (Couldn't open eyes most of time by then too weak,weak,) and DEHYDRATION (must have been dehydrated) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C04M20A and 025L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX on 01-May-2021. Concurrent medical conditions included Psoriatic arthritis since 1998, Glaucoma since 2003, Hypertension (Currently off HTN Rx) since 2013, Drug allergy (Allergy to Versed) and Drug allergy (Allergy to Enbrel). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, FUROSEMIDE (LASIX [FUROSEMIDE]) from an unknown date to 01-Jul-2021 for Dependent edema, LISINOPRIL from an unknown date to 15-Jun-2021 for Hypertension, ADALIMUMAB (HUMIRA) for PSA, HYDROCORTISONE (HUMERA), TIMOLOL, CRANBERRY [VACCINIUM MACROCARPON], VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, COPPER GLUCONATE, TOCOPHERYL ACID SUCCINATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (AREDS 2 VISUAL ADVANTAGE) and ZINC for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 05-Jan-2021, the patient experienced MALAISE (feeling generally unwell, felt sicker than the flu,). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to make it to the door), ASTHENIA (Couldn't open eyes most of time by then too weak,weak,) and DEHYDRATION (must have been dehydrated). The patient was treated with OSELTAMIVIR PHOSPHATE (TAMIFLU) at an unspecified dose and frequency; ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 05-May-2021, MALAISE (feeling generally unwell, felt sicker than the flu,), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to make it to the door), ASTHENIA (Couldn't open eyes most of time by then too weak,weak,) and DEHYDRATION (must have been dehydrated) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, Fibrin D dimer: positive (Positive) Positive. On 01-May-2021, Influenza A virus test: positive (Positive) Positive. On 01-May-2021, White blood cell count: abnormal (abnormal) White blood count below 6, WBC rose 2-3 points over normal baseline. On 01-Jul-2021, COVID-19: positive Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant drugs included probiotic and ASA 81  Verbatim term Included Positive for Flu A without fever or WBC reaction. Clinic doc thought I was having CVA or PE and sent by ambulance to ER Treatment information Included urgent care, r/o CVA vs PE, Rainbow labs, CT, CTA diagnostics, IV fluids Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant FU